title: The effect of different iron compounds on transferrin receptor expression in term human cytotrophoblast cells.
abstract: During pregnancy, the mother is faced with an increased food demand. A good example of this increased demand is iron (Fe). Fe is needed in all growing cells. During pregnancy, the Fe transport to the fetus increases enormously. This amount can easily induce an Fe deficiency in the mother. Fe supplementation is very important for her, but not for the Fe status of the fetus, which is protected against Fe toxicity as well as deficiency. The placenta seems to be autonomous in Fe uptake. Likely there is a regulation mechanism. The human placenta is hemomonochorial. The cell layer of the fetus in contact with the maternal blood is formed by syncytiotrophoblasts. Fe is transported to the placenta by transferrin. Transferrin binds to a transferrin receptor on the trophoblast membrane and is internalized via an endocytic pathway. During this cycle, Fe is released from transferrin and the transferrin-transferrin receptor complex is recycled to the membrane. Isolated trophoblast cells from term placentas form a syncytium in vitro, and transferrin receptors are expressed. Expression depends on the number of cells in culture, culture time, the amount of Fe available, and the Fe compound. By regulation of the number of transferrin receptors, trophoblasts are able to control their Fe uptake.
authors.affiliation: Department of Chemical Pathology, Rotterdam, The Netherlands.
authors.forename: J S
authors.initials: JS
authors.lastname: Starreveld
authors.forename: A M
authors.initials: AM
authors.lastname: Abdoel
authors.forename: J P
authors.initials: JP
authors.lastname: van Dijk
authors.forename: M J
authors.initials: MJ
authors.lastname: Kroos
authors.forename: H G
authors.initials: HG
authors.lastname: van Eijk
mesh_terms: D001665:Binding Sites; D001693:Biological Transport, Active; D002478:Cells, Cultured; D005260:Female; D005290:Ferric Compounds / Q000494:pharmacology*; D006801:Humans; D007501:Iron / Q000378:metabolism*; D009571:Nitrilotriacetic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D011247:Pregnancy; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D011990:Receptors, Transferrin / Q000187:drug effects / Q000378:metabolism*; D014168:Transferrin / Q000378:metabolism / Q000494:pharmacology*; D014327:Trophoblasts / Q000187:drug effects / Q000378:metabolism*
chemical_list: D005290:Ferric Compounds; D000644:Quaternary Ammonium Compounds; D011990:Receptors, Transferrin; D014168:Transferrin; D007501:Iron; D009571:Nitrilotriacetic Acid; C013531:ferric ammonium citrate; C020326:ferric nitrilotriacetate